Ashwagandha: Safe at 250-600 mg/day (Thyroid Risk)

Ashwagandha (Withania somnifera) extracts are commonly used at roughly 300–600 mg/day in many trials, though products vary widely. Case reports have linked high-dose or long-term use to liver injury in susceptible individuals, and thyroid hormone effects can occur, hyperthyroid symptoms are a documented concern in some contexts. Ashwagandha is also frequently stacked with other sedating herbs and magnesium, increasing side-effect overlap. Ashwagandha interacts with thyroid axis measurements in susceptible users and adds sedation when combined with anxiolytics or sleep stacks. Rare hepatotoxicity case reports involve blends; new jaundice after starting a product should trigger cessation and urgent evaluation. Treat each bottle as a line item with dose, frequency, and ingredient form—not only a brand name. NutriAudit normalizes units, flags duplicate nutrient paths across products, and surfaces totals that approach tolerable upper intake levels from authoritative references. Use the export as a conversation starter with your clinician before surgery, pregnancy, new prescriptions, or whenever symptoms shift alongside product changes. Retail marketing and percent daily value lines do not replace summing the same vitamin or mineral across every source you actually take in a day. Proprietary blends still leave you responsible for recognizable vitamins and minerals underneath; photograph both the marketing panel and the Supplement Facts table when you open a new bottle so later dose reconstruction does not depend on memory alone. Fat-soluble vitamins accumulate in tissue stores, so chronic modest excess can matter even when each individual dose “looks fine” relative to a marketing claim. Water-soluble vitamins are cleared faster, yet several still have real ULs, vitamin C, vitamin B6, and niacin are common examples, or predictable dose-dependent side effects at chronic high intake. Minerals such as iron, zinc, copper, selenium, and iodine participate in narrow therapeutic windows where deficiency and toxicity are both clinically relevant. Electrolytes like potassium become dangerous quickly when kidney function declines or when RAAS-inhibiting medications are present. Herbal and adaptogen categories add pharmacologic variability even when labels say “natural.” Thinking in categories, fat-soluble, UL minerals, sedating herbals, enzyme-inducing herbals, helps prioritize what to audit first. Gut health hype popularizes probiotics, prebiotics, digestive enzymes, and fiber powders simultaneously, sometimes provoking bloating instead of relief. Post-antibiotic probiotic timing is debated; immunocompromised hosts face infection risk from live cultures; SIBO presentations worsen for some with certain strains. Pancreatic insufficiency and celiac disease require medical enzyme and diet strategies, not guesswork stacks. Acid suppression changes upper GI flora and nutrient extraction. If diarrhea is bloody, febrile, or severe, stop experimenting and seek urgent care rather than doubling probiotic CFUs. Acute overdose scenarios differ from chronic UL creep. A child ingesting iron tablets is an emergency; an adult slowly exceeding zinc UL with lozenges plus multis is a subacute deficiency-risk pattern for copper. Some nutrients cause unmistakable acute GI signals, magnesium diarrhea, vitamin C loose stools, niacin flushing, while others damage quietly until labs flag liver enzymes or calcium. Poison control and emergency services exist for sudden ingestions; outpatient clinicians handle gradual drift when patients bring complete product lists. Photographing labels helps when bottles are left at home. Do not induce vomiting unless directed by professionals. FDA Dietary Reference Intakes publish Recommended Dietary Allowances and Tolerable Upper Intake Levels so consumers and clinicians can compare habitual intake to evidence-based safety envelopes. Those numbers assume you add every relevant source in a day: tablets, capsules, powders, functional beverages, and sometimes fortified foods that repeat the same nutrient under unfamiliar names. When two products both say “immune support” but one lists ascorbic acid and another lists mineral ascorbates, your audit still has to treat them as the same vitamin C ledger entry. The same aggregation rule applies to retinol esters, multiple forms of magnesium salts, and duplicate B vitamins across energy products. NutriAudit’s overlap engine is designed to mirror that regulatory mindset: totals first, brand stories second. If your summed intake approaches or exceeds a UL, the next step is clinician review, not another retail product to “balance” the stack without labs. Supplement facts panels round numbers and sometimes list proprietary blends without gram-for-gram transparency for every ingredient. That opacity matters less for trace novelty compounds and more for nutrients with defined ULs, where small per-serving amounts still become dangerous when four products share the same category. Serving size tricks also distort perception: “two tablets daily” doubles the printed per-tablet dose, and powders measured with unpacked scoops vary wildly. International units for vitamins A, D, and E require conversion before you can compare totals to milligram or microgram UL tables. If you travel or import products, label conventions differ; relying on percent daily value alone is risky because DV targets are not identical to UL ceilings. A disciplined audit writes down each product, dose, and frequency, then converts units once. NutriAudit encourages you to export a single stack summary for clinicians whenever totals approach reference limits or when new symptoms coincide with product changes. Revisit the audit after hospital discharge, a course of antibiotics, intentional weight loss, or any sustained diet pattern shift that changes what you eat every day.